您的位置:首页 > 会议日程
Hyoung Jin KANG
分享到:
Seoul National University Hospital Seoul National University Hospital

A. Education/Training/License

 

Education

1987-1989     Seoul National University, Pre-medical course

1989-1993     Seoul National University College of Medicine

2000-2003     Seoul National University College of Medicine, Master of Pediatrics

2003-2005     Seoul National University College of Medicine, Ph.D. of Molecular and Clinical Oncology

 

Training

1993-1994     Medical Internship, Seoul National University Hospital

1994-1998     Medical Residency, Pediatrics, Seoul National University Hospital

1998-2001     Research Associate, Biomedical Science, Korean National Institute of Health

2001-2003     Fellowship, Pediatrics, Seoul National University Hospital, Seoul

2009-2010     PostDoc Fellow, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston             

 

License

1993           M.D.

1998           Board of Pediatrics

2008     Board of Pediatric Hematology-Oncology

 

 

B. Positions and Membership

 

Academic Appointments

 

2003-2005     Scientific Researcher, Pediatric Oncology Branch, National Cancer Center, Gyeonggi, Goyang

2005-2007     Contractual Professor of Pediatrics,

                      Seoul National University Hospital, Seoul

2007-2011     Assistant Professor for Clinic of Pediatrics,

                    Seoul National University Hospital, Seoul

2011-2016     Associate Professor of Pediatrics,

                    Seoul National University College of Medicine, Seoul National University Hospital, Seoul

2016-     Professor of Pediatrics,

                    Seoul National University College of Medicine, Seoul National University Hospital, Seoul

 

Other Experience and Professional Memberships

 

2001-           Member, Korean Society of Pediatric Hematology and Oncology

2001-           Member, Korean Society of Blood and Marrow Transplantation

2003-          Member, American Society of Hematology

2004-          Member, Korean Society of Hematology

2004-           Member, Korean Cancer Association

2004-           Member, Korean Society of Gene and Cell Therapy

2005-2009, 2011-2015 Member of Scientific Committee, Korean Society of Blood and Marrow Transplantation

2006-     Member, Korean Society of Gene and Cell Therapy

2006-2009, 2013-2016   Manager of Clinical Science, Korean Society of Gene and Cell Therapy

2007-2009, 2011-2014 Member of Scientific Committee, Korean Society of Hematology

2012-     Member of Academic Committee, Korea Marrow Donor Program

2012-     Member of Coordination Committee, Korea Marrow Donor Program

2012-2014     Expert of Central Drug Review and Assessment Committee, Ministry of Food and Drug Safety

2012-2014     Member of Biopharmaceutical Agent Review and Assessment Committee,

    Ministry of Food and Drug Safety

2013-2019     Chairs of Transplant Registration Committee, Korean Society of Blood and Marrow

 Transplantation 

2013-2017     Member of Cancer Treatment Review and Assessment Committee,

    National Health Insurance Review & Assessment Service

2013-2017     Director of Legislation, Korean Society of Pediatric Hematology and Oncology 

2014-2016     Head of Research Policy, Seoul National University College of Medicine  

2015-2018     Director of Policy Planning, Korean Society of Hematology

2015-     Member of Board of Directors, Korea Childhood Leukemia Foundation

2016-     Member of Board of Directors, Korea Cancer Association

2016-2019     Member of Registry Committee, Asia-Pacific Blood and Marrow Transplantation Group

2016-     Member of Scientific Committee, Asia-Pacific Blood and Marrow Transplantation Group

2017-     Vice president, Korean Society of Gene and Cell Therapy

2017-           Chief of Children and Adolescent Cancer Center, Seoul National University Childrens Hospital

2018-2019     Director of Policy Planning, Korean Society of Pediatric Hematology-Oncology

2018-     Chair, Childhood ALL Working Party, Korean Society of Hematology

2018-     Chair, ALL Committee of Pediatric Hematology-Oncology Study Group,

Korean Society of Pediatric Hematology-Oncology

2018-       Chair, Immune Cell and Gene Therapy Research Group,

Korean Society of Gene and Cell Therapy

2018-     Expert of Central Drug Review and Assessment Committee, Ministry of Food and Drug Safety

2019-2020     Director of Scientific Committee, Korean Society of Hematology

Chair of Scientific Committee, International Conference of Korean Society of Hematology

2019-     Director of Scientific Committee, Korean Society of Pediatric Hematology-Oncology

2019-     Chair of Clinical Trials Committee, Korean Society of Blood and Marrow Transplantation

2020-     Director of Medical Info. & Social Cooperation, Korean Society of Hematology

 

C. Honors and Award

 

2003           Young Investigators Grants, 7th International Symposium on Myelodysplastic Syndrome

2004           Good Presentation Award,

                    9th Symposium of Korean Society of Blood and Marrow Transplantation

2004           Best Presentation Award,

                    23th Symposium of Korean Society of Pediatric Hematology and Oncology

2005           Good Presentation Award,

                    10th Symposium of Korean Society of Blood and Marrow Transplantation

2005           Best Presentation Award,

                    24th Symposium of Korean Society of Pediatric Hematology and Oncology

2007           Good Presentation Award,

                    11th Symposium of Korean Society of Blood and Marrow Transplantation

2009           Good Presentation Award,

                    50th Symposium of Korean Society of Hematology

2012     Excellent Investigator Award

                      53th Symposium of Korean Society of Hematology

2013     Professor of the year 2012 (Medical part), Seoul National University Hospital

2014     Best abstract award

    5th Asian Cell Therapy Organization Annual Meeting

2015     10th Korean Foundation for Cancer Research Award

2016     Hamchoon Research Award

    Seoul National University College of Medicine

2016     Minister of Health and Welfare Award

    Health and Medical Technology Development Government Award

2020     Korean Society of Blood and Marrow Transplantation

Leading Researcher Award   

 

D. Selected peer-reviewed SCI(E) publications (in chronological order)

 

1. Kang HJ, Kim SC, Kim YJ, Kim CW, Kim JG, Ahn HS, Park SI, Jung MH, Choi BC, Kimm K. Short-term phytohaemagglutinin-activated mononuclear cells induce endothelial progenitor cells from cord blood CD34+ cells. Br J Haematol. 2001 Jun;113(4):962-9

 

2. Kang HJ, Shin HY, Choi HS, Ahn HS. Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML). Leuk Res. 2004 Feb;28(2):167-70.

 

3. Kang HJ, Shin HY, Choi HS, Han KS, Ahn HS. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia. Bone Marrow Transplant. 2004 Mar;33(5):471-6.

 

4. Ryu KH, Cho SJ, Jung YJ, Seoh JY, Kie JH, Koh SH, Kang HJ, Ahn HS, Shin HY. In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method. Int J Hematol. 2004 Oct;80(3):281-6.

 

5. Kang HJ, Shin HY, Choi HS, Ahn HS. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant. 2004 Dec;34(11):939-943.

 

6. Koh SH, Choi HS, Park ES, Kang HJ, Ahn HS, Shin HY. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death. Biochem Biophys Res Commun. 2005 Apr 15;329(3):1039-45.

 

7. Kang HJ, Hong S, Kim I, Park B, Han KS, Cho HI, Shin HY, Ahn HS. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia. Leuk Res. 2005 Jun;29(6):617-23.

 

8. Shin HY, Kang HJ, Park ES, Choi HS, Ahn HS, Kim SY, Chung NG, Kim HK, Kim SY, Kook H, Hwang TJ, Lee KC, Lee SM, Lee KS, Yoo KH, Koo HH, Lee MJ, Seo JJ, Moon HN, Ghim T, Lyu CJ, Lee WS, Choi YM, Recombinant urate oxidase (rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: results of a compassionate prospective multicenter study in Korea. Pediatr Blood & Cancer. 2006 Apr;46(4):439-45.

 

9. Park ES, Kang HJ, Shin HY, Ahn HS. Improved Survival in Patients with Recurrent Wilms Tumor: the Experience of the Seoul National University Children's Hospital. J Korean Med Sci. 2006 Jun;21(3):436-40.

 

10. Kang HJ, Kho SH, Jang MK, Lee SH, Shin HY, Ahn HS. Early engraftment kinetics of two units cord blood transplantation. Bone Marrow Transplant. 2006 Aug;38(3):197-201.

 

11. Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, Koo HH, Kim HJ, Kang HJ, Shin HY, Ahn HS. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood. 2007 Jan 15;109(2):471-7.

 

12. Park JY, Lee S, Kang HJ, Kim HS, Park SY. Primary Ewing's sarcoma-primitive neuroectodermal tumor of the uterus: A case report and literature review. Gynecol Oncol. 2007 Aug;106(2):427-32.

 

13. Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS. Control of extended-spectrum {beta}-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother. 2007 Sep;60(3):629-37.

 

14. Kim EK, Kang HJ, Park JA, Choi HS, Shin HY, Ahn HS. Retrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastoma. J Korean Med Sci. 2007 Sep;22 Suppl:S66-72.

 

15. Seo YJ, Koh SH, Kang HJ, Shin HY, Jeong G, Ahn HS. Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation. Biochem Biophys Res Commun. 2007 Dec 14;364(2):388-94

 

16. Kang HJ, Shin HY, Ko SH, Park JA, Kim EK, Rhim JW, Kim JG, Ahn HS. Unrelated bone marrow transplantation with a reduced toxicity myeloablative conditioning regimen in Wiskott-Aldrich syndrome. J Korean Med Sci. 2008 Feb;23(1):146-8.

 

17. Park JA, Yun JH, Kang HJ, Shin HY, Ahn HS. Acute intestinal pseudo-obstruction after induction treatment of relapsed acute promyelocytic leukemia with arsenic trioxide. Pediatr Blood Cancer. 2008 Apr;50(4):872-4.

 

18. An SB, Cheon JE, Kim IO, Kim WS, Ahn HS, Shin HY, Kang HJ, Yeon KM. Granulocytic sarcoma presenting with necrotic cervical lymph nodes as an initial manifestation of childhood leukaemia: imaging features. Pediatr Radiol. 2008 Jun;38(6):685-7.

 

19. Kang HJ, Oh Y, Chun SM, Seo YJ, Shin HY, Kim CW, Ahn HS, Han BD. TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia. Mol Cell Probes. 2008 Jun;22(3):193-200.

 

20. Eom KY, Kim IH, Park CI, Kim HJ, Kim JH, Kim K, Kim SK, Wang KC, Cho BG, Jung HW, Heo DS, Kang HJ, Shin HY, Ahn HS. Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed. Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):667-71.

 

21. Lee HR, Kang SH, Kang HJ, Shin HY, Ahn HS, Kim HK, Park MH, Cho HI, Lee DS. Lineage switch from acute myeloid leukemia to biphenotypic acute leukemia with acquisition of Philadelphia chromosome. Cancer Genet Cytogenet. 2008 Jul 15;184(2):124-6.

 

22. Bang SM, Ahn JY, Park J, Park SH, Park J, Cho EK, Shin DB, Lee JH, Yoo SJ, Jeon IS, Kim YK, Kim HJ, Kim HN, Lee IK, Kang HJ, Shin HY, Ahn HS. Low Frequency and Variability of FLT3 Mutations in Korean Patients with Acute Myeloid Leukemia. J Korean Med Sci. 2008 Oct;23(5):833-837.

 

23. Lee KM, Ward MH, Han S, Ahn HS, Kang HJ, Choi HS, Shin HY, Koo HH, Seo JJ, Choi JE, Ahn YO, Kang D. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res. 2009 Feb;33(2):250-258.

 

24. Yoon JH, Park JA, Kim EK, Kang HJ, Shin HY, Ahn HS. Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia. J Korean Med Sci. 2009 Apr;24(2):281-8.

 

25. Lee JW, Kang HJ, Park JD, Shin HY, Ahn HS. Early pulmonary complications after hematopoietic stem cell transplantation in pediatric patients: association with cytomegalovirus infection. J Pediatr Hematol Oncol. 2009 Aug;31(8):545-51.

 

26. Lee JW, Kang HJ, Kim EK, Shin HY, Ahn HS. Successful salvage unrelated umbilical cord blood transplantation with two units after engraftment failure with single unit in severe aplastic anemia. J Korean Med Sci. 2009 Aug;24(4):744-6

 

27. Kim M, Kang HJ, Shin HY, Ahn HS, Lee DS. Concurrent langerhans cell histiocytosis and B-lineage lymphoid proliferation in the bone marrow. Korean J Lab Med. 2009 Oct;29(5):402-5. PMID:19893348

 

28. Kim M, Yim SH, Cho NS, Kang SH, Ko DH, Oh B, Kim TY, Min HJ, She CJ, Kang HJ, Shin HY, Ahn HS, Yoon SS, Kim BK, Shin HR, Han KS, Cho HI, Lee DS. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet Cytogenet. 2009 Nov;195(1):59-65.

 

29. Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS. Effect of iron overload and iron chelating therapy on allogeneic hematopoietic stem cell transplantation in children. Bone Marrow Transplant. 2009 44(12):793-7.

 

30. Song EY, Kang HJ, Shin HY, Ahn HS, Kim I, Yoon SS, Park S, Kim BK, Park MH. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients. Hum Immunol. 2010 Jan;71(1):88-92.

 

31. Lee DH, Chung NG, Cho B, Kim HK, Kang HJ, Shin HY, Ahn HS, Yoo KH, Sung KW, Koo HH, Kook H, Hwang TJ, Im HJ, Seo JJ, Park HJ. Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea. J Korean Med Sci. 2010 Jan;25(1):9-15.

 

32. Lee JY, Kim BS, Phi JH, Kang HJ, Park SH, Wang KC, Kim IH, Cho BK, Kim SK. Primary meningeal rhabdomyosarcoma associated with chronic subdural effusion. J Neurosurg Pediatr. 2010 Feb;5(2):167-71. PMID: 20121365

 

33. Yoon HS, Kim HJ, Yoo KH, Sung KW, Koo HH, Kang HJ, Shin HY, Ahn HS, Kim JY, Lim YT, Bae KW, Lee KO, Shin JS, Lee ST, Chung HS, Kim SH, Park CJ, Chi HS, Im HJ, Seo JJ. The UNC13D gene is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis. Haematologica. 2010 Apr;95(4):622-6.

 

34. Sung KW, Ahn HS, Cho B, Choi YM, Chung NG, Hwang TJ, Im HJ, Jeong DC, Kang HJ, Koo HH, Kook H, Kim HK, Lyu CJ, Seo JJ, Shin HY, Yoo KH, Won SC, Lee KS. Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005). J Korean Med Sci. 2010 May;25(5):691-7.

 

35. Kang HJ, Lee JW, Kim H, Shin HY, Ahn HS. Successful first-line treatment with double umbilical cord blood transplantation in severe aplastic anemia. Bone Marrow Transplant. 2010 May;45(5):955-6.

 

36. Kang HJ, Lee JW, Kho SH, Kim MJ, Seo YJ, Kim H, Shin HY, Ahn HS. High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia. J Korean Med Sci. 2010 Jun;25(6):841-5.

 

37. Han S, Lan Q, Park AK, Lee KM, Park SK, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Ahn YO, Chanock SJ, Kim H, Rothman N, Kang D. Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol. 2010 Jul;71(7):727-30.

 

38. Park JE, Kang J, Yoo KH, Sung KW, Koo HH, Lim do H, Shin HJ, Kang HJ, Park KD, Shin HY, Kim IH, Cho BK, Im HJ, Seo JJ, Park HJ, Park BK, Ahn HS. Efficacy of High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Relapsed Medulloblastoma: A Report on The Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 Study. J Korean Med Sci. 2010 Aug;25(8):1160-6.

 

39. Lee SH, Yoo KH, Sung KW, Koo HH, Kwon YJ, Kwon MM, Park HJ, Park BK, Kim YY, Park JA, Im HJ, Seo JJ, Kang HJ, Shin HY, Ahn HS. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transplant. 2010 Aug;45(8):1287-93.

 

40. Choi HS, Park ES, Kang HJ, Shin HY, Noh CI, Yun YS, Ahn HS, Choi JY. Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors. J Korean Med Sci. 2010 Sep;25(9):1336-42.

 

41. Yoon HS, Im HJ, Moon HN, Lee JH, Kim HJ, Yoo KH, Sung KW, Koo HH, Kang HJ, Shin HY, Ahn HS, Cho B, Kim HK, Lyu CJ, Lee MJ, Kook H, Hwang TJ, Seo JJ. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2010 Sep 1;14(6):735-40.

 

42. Han S, Lee KM, Park SK, Lee JE, Ahn HS, Shin HY, Kang HJ, Koo HH, Seog JJ, Choi JE, Ahn YO, Kang D. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res. 2010 Oct;34(10):1271-1274.

 

43. Kang HJ, Yoo KH, Lee JW, Kim H, Lee SH, Sung KW, Park KD, Koo HH, Shin HY, Ahn HS. Double umbilical cord blood transplantation for children and adolescents. Ann Hematol. 2010 Oct;89(10):1035-44.

 

44. Kang HJ, Shin HY, Park JE, Chung NG, Cho B, Kim HK, Kim SY, Lee YH, Lim YT, Yoo KH, Sung KW, Koo HH, Im HJ, Seo JJ, Park SK, Ahn HS; The Korean Society of Pediatric Hematology-Oncology. Successful engraftment with fludarabine, cyclophosphamide and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multi-center study. Biol Blood Marrow Transplant. 2010 Nov;16(11):1582-8.

 

45. Kim SJ, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang DH, Kook H, Kang HJ, Ahn HS, Yoon SS, Sohn SK, Min YH, Min WS, Park HS, Won JH. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: Results from a prospective multicenter phase II study. Haematologica. 2010 Nov;95(11):1935-42.

 

46. Kim TJ, Kim N, Kang HJ, Kim EO, Kim ST, Ahn HS, Bluestone JA, Lee KM. FK506 causes cellular and functional defects in human natural killer cells. J Leukoc Biol. 2010 Dec;88(6):1089-1097.

 

47. Yoo KH, Lee SH, Sung KW, Koo HH, Chung NG, Cho B, Kim HK, Kang HJ, Shin HY, Ahn HS, Baek HJ, Han DK, Kook H, Hwang TJ, Kim SY, Lee YH, Hah JO, Im HJ, Seo JJ, Park SK, Jung HJ, Park JE, Lim YJ, Park SS, Lim YT, Yoo ES, Ryu KH, Park HJ, Park BK. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol. 2011 Jan;86(1):12-7.

 

48. Park HJ, Oh Y, Kang HJ, Han EJ, Shin HY, Ahn HS, Ahn KS, Yoon BH, Han BD. A gene-specific primer extension and liquid bead array system for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens. 2011 Mar;77(3):251-6. PMID: 21299533

 

49. Jeong DC, Chung NG, Kang HJ, Koo HH, Kook H, Kim SK, Kim SY, Kim HS, Kim HM, Park KD, Park SK, Park JS, Park JE, Park HJ, Park YS, Seo JJ, Sung KW, Shin HY, Ahn HS, Ryu KH, Ryu KH, Yoo ES, Lyu CJ, Lee KS, Lee KC, Lee SY, Lee YH, Lim YT, Lim YJ, Jung HL, Cho B, Choi YM, Hah JO, Hwang TJ, Kim HK. Epidemiology and Clinical Long-term Outcome of Childhood Aplastic Anemia in Korea for 15 Years: Retrospective Study of the Korean Society of Pediatric Hematology Oncology (KSPHO). J Pediatr Hematol Oncol. 2011 Apr;33(3):172-178.

 

50. Kim MS, Kang HJ, Park HJ, Yook YJ, Han BD, Kim CW, Kim NH, Lee JW, Kim H, Park KD, Shin HY, Ahn HS. Development of multiplex PCR method for the analysis of glutathione s-transferase polymorphism. Mol Diagn Ther. 2011 Oct 1;15(5):285-92.

 

51. Kang HJ, Bartholomae CC, Paruzynski A, Arens A, Kim S, Yu SS, Hong Y, Joo CW, Yoon NK, Rhim JW, Kim JG, Von Kalle C, Schmidt M, Kim S, Ahn HS. Retroviral Gene Therapy for X-linked Chronic Granulomatous Disease: Results From Phase I/II Trial. Mol Ther. 2011 Nov;19(11):2092-101.

 

52. Ko DH, Jeon Y, Kang HJ, Park KD, Shin HY, Kim HK, Cho HI, Ahn HS, Lee DS. Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker. Br J Haematol. 2011 Nov;155(4):530-3.

 

53. Ahn YH, Kang HJ, Shin HY, Ahn HS, Choi Y, Kang HG. Tumour lysis syndrome in children: experience of last decade. Hematol Oncol. 2011 Dec;29(4):196-201.

 

54. Park S, Kang HJ, Cho SI, Kim SY, Seong MW, Park SS. A case report of a male patient with Hb Hammersmith [β42(CD1)PheSer, TTT>TCT]. Hemoglobin. 2012;36(2):161-5.

 

55. Song N, Han S, Lee KM, Choi JY, Park SK, Jeon S, Lee Y, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Kang D. Genetic Variants in Interleukin-2 and Risk of Lymphoma among Children in Korea. Asian Pac J Cancer Prev. 2012;13(2):621-3.

 

56. Han S, Koo HH, Lan Q, Lee KM, Park AK, Park SK, Sung H, Ahn HS, Shin HY, Kang HJ, Seo JJ, Ahn YO, Kim H, Rothman N, Kang D. Common variation in genes related to immune response and risk of childhood leukemia. Hum Immunol. 2012 Mar;73(3):316-9.

 

57. Hong KT, Kang HJ, Kim NH, Kim MS, Lee JW, Kim H, Park KD, Shin HY, Ahn HS. Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment. J Hematol Oncol. 2012 Mar 30;5(1):14.

 

58. Kim H, Kang HJ, Lee JW, Park KD, Shin HY, Ahn HS. Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences. Ann Hematol. 2012 May;91(5):751-8.

 

59. Lee JW, Kang HJ, Lee SH, Yu K, Kim NH, Yuk YJ, Jang MK, Han EJ, Kim H, Park KD, Shin HY, Jang I, Ahn HS. Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: Phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling. Biol Blood Marrow Transplant. 2012 Jun;18(6):944-50.

 

60. Park C, Han S, Lee KM, Choi JY, Song N, Jeon S, Park SK, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Kang D. Association between CASP7 and CASP14 genetic polymorphisms and the risk of childhood leukemia. Hum Immunol. 2012 Jul;73(7):736-9.

 

61. Lee HJ, Park S, Kang HJ, Jun JK, Lee JA, Lee DS, Park SS, Seong MW. A case report of fanconi anemia diagnosed by genetic testing followed by prenatal diagnosis. Ann Lab Med. 2012 Sep;32(5):380-4.

 

62. Jeon YK, Go H, Nam SJ, Keam B, Kim TM, Jung KC, Kang HJ, Lee DS, Huh JR, Park SH. Expression of the promyelocytic leukemia zinc-finger in T-lymphoblastic lymphoma and leukemia has strong implications for their cellular origin and greater association with initial bone marrow involvement. Mod Pathol. Mod Pathol. 2012 Sep;25(9):1236-45.

 

63. Kim H, Kang HJ, Kim HJ, Jang MK, Kim NH, Oh Y, Han BD, Choi JY, Kim CW, Lee JW, Park KD, Shin HY, Ahn HS. Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism. PLoS One. 2012;7(9):e45558. 2012 Sep 24.

 

64. Yoon JH, Kang HJ, Kim H, Lee JW, Park JD, Park KD, Shin HY, Ahn HS. Successful Treatment of Primary Central Nervous System Lymphoma without Irradiation in Children: Single Center Experience. J Korean Med Sci. 2012 Nov;27(11):1378-84.

 

65. Kim H, Kim NH, Kang HJ, Lee JW, Kim MS, Park KD, Shin HY, Ahn HS. Successful long-term use of imatinib mesylate in pediatric patients with sclerodermatous chronic GVHD. Pediatr Transplant. 2012 Dec;16(8):910-2.

 

66. Choi JH, Choi EH, Kang HJ, Park KD, Park SS, Shin HY, Lee HJ, Ahn HS. Respiratory viral infections after hematopoietic stem cell transplantation in children. J Korean Med Sci. 2013 Jan;28(1):36-41.

 

67. Chung SJ, Park SW, Kim MK, Kang MJ, Lee YA, Lee SY, Shin CH, Yang SW, Kang HJ, Park KD, Shin HY, Ahn HS. Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia. J Korean Med Sci. 2013 Jan;28(1):106-13.

 

68. Seo JY, Song JS, Lee KO, Won HH, Kim JW, Kim SH, Lee SH, Yoo KH, Sung KW, Koo HH, Kang HJ, Shin HY, Ahn HS, Han DK, Kook H, Hwang TJ, Lyu CJ, Lee MJ, Kim JY, Park SS, Lim YT, Kim BE, Koh KN, Im HJ, Seo JJ, Kim HJ; on behalf of the Korea Histiocytosis Working Party. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea. Ann Hematol. 2013 Mar;92(3):357-64.

 

69. Hong KT, Kang HJ, Kim NH, Kim MS, Lee JW, Kim H, Park KD, Shin HY, Ahn HS. Peri-engraftment syndrome in allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013 Apr;48(4):523-8.

 

70. Park M, Lee SH, Lee YH, Yoo KH, Sung KW, Koo HH, Kang HJ, Park KD, Shin HY, Ahn HS, Chung NG, Cho B, Kim HK, Koh KN, Im HJ, Seo JJ, Han DK, Baek HJ, Kook H, Hwang TJ, Lee EK, Hah JO, Lim YJ, Jung HJ, Park JE, Jang MJ, Chong SY, Oh D. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2013 Apr;19(4):640-6.

 

71. Seo S, Ahn H, Yu Y, Kang H, Park K, Cho S, Park J, Hyun Y, Kim J, Seong MW, Park S. Mutation spectrum of RB1 gene in Korean bilateral retinoblastoma patients using direct sequencing and gene dosage analysis. Clin Genet. 2013 May;83(5):494-6.

 

72. Lee JW, Kang HJ, Choi JY, Kim NH, Jang MK, Yeo CW, Lee SS, Kim H, Park JD, Park KD, Shin HY, Shin JG, Ahn HS. Pharmacogenetic study of deferasirox, an iron chelating agent. PLoS One. 2013 May 30;8(5):e64114. PMID: 23737969

 

73. Lee YW, Yang EA, Kang HJ, Yang X, Mitsuiki N, Ohara O, Miyawaki T, Kanegane H, Lee JH. Novel mutation of IL2RG gene in a Korean boy with X-linked severe combined immunodeficiency. J Investig Allergol Clin Immunol. 2013;23(1):65-7. PMID: 23653982

 

74. Jeon S, Han S, Lee K, Choi J, Park SK, Park AK, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Kim H, Ahn Y, Kang D. Genetic variants of AICDA/CASP14 associated with childhood brain tumor. Genet Mol Res. 2013 Jun 20;12(2):2024-31. PMID: 23408445

 

75. Baek HJ, Park HJ, Sung KW, Lee SH, Han JW, Koh KN, Im HJ, Kang HJ, Park KD. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study. J Neurooncol. 2013 Sep;114(3):329-38. PMID:23824533

 

76. Kim H, Kang HJ, Lee JW, Park JD, Park KD, Shin HY, Ahn HS. Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients. Childs Nerv Syst. 2013 Oct;29(10):1851-8. PMID: 23748464

 

77. Hong CR, Kang HJ, Lee JW, Kim H, Kim NH, Park KD, Park JD, Seong MW, Park SS, Shin HY, Ahn HS. Clinical characteristics of pediatric thalassemia in Korea: a single institute experience. J Korean Med Sci. 2013 Nov;28(11):1645-9. PMID:24265529

 

78. Park HJ, Yang HK, Shin DW, Kim YY, Kim YA, Yun YH, Nam BH, Bhatia S, Park BK, Ghim TT, Kang HJ, Park KD, Shin HY, Ahn HS. Cross-cultural adaptation of the korean version of the minneapolis-manchester quality of life instrument-adolescent form. J Korean Med Sci. 2013 Dec;28(12):1788-95. PMID:24339710

 

79. Moon SY, Lim MK, Hong S, Jeon Y, Han M, Song SH, Lim KS, Yu KS, Jang IJ, Lee JW, Kang HJ, Song J. Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry. Ann Lab Med. 2014 Jan;34(1):7-14. PMID:24422189

 

80. Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH, Lee JW, Park KD, Shin HY, Kang HJ, Kwon O. Clinical characteristics of chemotherapy-induced alopecia in childhood. J Am Acad Dermatol. J Am Acad Dermatol. 2014 Mar;70(3):499-505PMID:24355411

 

81. Kim BE, Koh KN, Suh JK, Im HJ, Song JS, Lee JW, Kang HJ, Park KD, Shin HY, Choi HS, Lee SH, Yoo KH, Sung KW, Koo HH, Jung HL, Chung NG, Cho B, Kim HK, Lyu CJ, Baek HJ, Kook H, Park JE, Park HJ, Park BK, Yoo ES, Ryu KH, Lee KS, Kim HS, Lee JM, Park ES, Yoon HS, Lee KC, Lee MJ, Lim YT, Kim HM, Park SK, Park JA, Kim SK, Park M, Lim YJ, Lee YH, Seo JJ; on the behalf of Korea Histiocytosis Working Party. Clinical Features and Treatment Outcomes of Langerhans Cell Histiocytosis: A Nationwide Survey From Korea Histiocytosis Working Party. J Pediatr Hematol Oncol. 2014 Mar;36(2):125-33. PMID:24276037

 

82. Park M, Lee YH, Kang HR, Lee JW, Kang HJ, Park KD, Shin HY, Ahn HS, Baek HJ, Kook H, Hwang TJ, Lee JW, Chung NG, Cho B, Kim HK, Lee SH, Yoo KH, Sung KW, Koo HH, Koh KN, Im HJ, Seo JJ, Park JE, Lim YJ, Lyu CJ, Lee JM, Hah JO; on behalf of the Korean Cord Blood Transplantation Working Party. Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents. Pediatr Transplant. 2014 Mar;18(2):221-9. PMID:24372660

 

83. Lee JW, Shin HY, Kang HJ, Kim H, Park JD, Park KD, Kim HS, Park SH, Wang KC, Ahn HS. Clinical characteristics and treatment outcome of langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center. Pediatr Hematol Oncol. 2014 Apr;31(3):293-302. PMID:24397251

 

84. Park JD, Kang HJ, Kim YA, Jo M, Lee ES, Shin HY, Yun YH. Trends in the aggressiveness of end-of-life care for Korean pediatric cancer patients who died in 2007-2010. PLoS One. 2014 Jun 12;9(6):e99888. 2014. PMID:24923320

 

85. Park HJ, Park M, Han M, Nam BH, Koh KN, Im HJ, Lee JW, Chung NG, Cho B, Kim HK, Yoo KH, Koo HH, Kang HJ, Shin HY, Ahn HS, Lim YT, Kook H, Lyu CJ, Hah JO, Park JE, Lim YJ, Seo JJ. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014 Sep;49(9):1212-6. PMID:25000455

 

86. Song S, Park HJ, Yoon JH, Kim DW, Park J, Shin D, Shin SH, Kang HJ, Kim SK, Phi JH, Kim JY. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors. Acta Oncol. 2014 Sep;53(9):1158-64. PMID:24913151

 

87. Lee JA, Choi SY, Kang HJ, Lee JW, Kim H, Kim JH, Sung KW, Shin HY, Ahn HS, Park KD. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases. Br J Ophthalmol. 2014 Oct;98(10):1355-9. PMID:24795337

 

88. Yoon JH, Kim H, Lee JW, Kang HJ, Park HJ, Park KD, Park BK, Shin HY, Park JD, Park SH, Ahn HS. Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor in the Adrenal Gland of an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2014 Oct;36(7):e456-9 PMID:24276043

 

89. Kim H, Park ES, Lee SH, Koo HH, Kim HS, Lyu CJ, Jun SE, Lim YT, Baek HJ, Kook H, Lee JW, Kang HJ, Park KD, Shin HY, Ahn HS. Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents. Cancer Res Treat. 2014 Oct;46(4):358-65. PMID:25043820

 

90. Garcia A, Yi NJ, Lee KB, Lee JM, Choi YR, Suh SW, You T, Lee KW, Park JD, Kang HJ, Kim JG, Kang EK, Hong G, Suh KS. Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: A case report. Pediatr Transplant. 2014 Nov;18(7):E240-5. PMID:25156688

 

91. Lee JW, Kang HJ, Kim S, Lee S, Yu KS, Kim NH, Jang MK, Kim H, Song SH, Park JD, Park KD, Shin HY, Jang IJ, Ahn HS. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily IV busulfan fludarabine etoposide regimen in pediatric and infant ALL patients. Biol Blood Marrow Transplant. Biol Blood Marrow Transplant. 2015 Jan;21(1):190-5. PMID:25255163

 

92. Koh KN, Im HJ, Chung NG, Cho B, Kang HJ, Shin HY, Lyu CJ, Yoo KH, Koo HH, Kim HJ, Baek HJ, Kook H, Yoon HS, Lim YT, Kim HS, Ryu KH, Seo JJ; the Korea Histiocytosis Working Party. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol. 2015 Jan;94(1):51-9. PMID:24935083

 

93. Yi Y, Kang HJ, Shin HY, Kim K. Progressive Myelopathy Mimicking Subacute Combined Degeneration After Intrathecal Chemotherapy. 2015 Feb;30(2):246-9. PMID:24659737

 

94. Park M, Lee YH, Lee SH, Yoo KH, Sung KW, Koo HH, Lee JW, Kang HJ, Park KD, Shin HY, Ahn HS, Lee JW, Chung NG, Cho B, Kim HK, Koh KN, Im HJ, Seo JJ, Baek HJ, Kook H, Hwang TJ, Lee JM, Hah JO, Lim YJ, Park JE, Lyu CJ, Lim YT, Chong SY, Oh D; on behalf of the Cord Blood Transplantation Working Party of the Korean Society of Hematology. Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients. Ann Hematol. 2015 Mar;94(3):481-9. PMID:25417830

 

95. Bae JW, Kim YH, Kim SK, Wang KC, Shin HY, Kang HJ, Park SH, Phi JH. Langerhans cell histiocytosis causing acute optic neuropathy. Childs Nerv Syst. 2015 Mar;94(3):481-9. PMID:25566821

 

96. Kang HJ, Loftus S, Taylor A, DiCristina C, Green S, Zwaan CM. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015 Apr;16(4):385-94. PMID:25770814

 

97. Choi JY, Kang HJ, Lee JW, Ju HY, Hong CR, Kim H, Yu YS, Park SH, Cheon JE, Park KD, Shin HY. Very Late Relapse of Bilateral Retinoblastoma. J Pediatr Hematol Oncol. 2015 May;37(4):e264-7. PMID:25757022

 

98. Green S, Zwaan CM, Kang HJ. Aprepitant for paediatric chemotherapy-induced nausea and vomiting - Authors' reply. Lancet Oncol. 2015 Jun;16(6):e260-1. PMID:26065616

 

99. Kim H, Shin D, Kang HJ, Yu KS, Lee JW, Kim SJ, Kim MS, Song ES, Jang MK, Park JD, Jang IJ, Park KD, Shin HY, Ahn HS. Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation. Clin Drug Investig. 2015 Jul;35(7):437-46. PMID:26022135

 

100. Hong CR, Kang HJ, Ju HY, Lee JW, Kim H, Park SH, Kim IH, Park KD, Shin HY. Extra-cranial Malignant Rhabdoid Tumor in Children: A Single Institute Experience. Cancer Res Treat. 2015 Oct;47(4):889-96. PMID:25672587

 

101. Hong CR, Kang HJ, Kim MS, Ju HY, Lee JW, Kim H, Kim HS, Park SH, Park KD, Park JD, Shin HY, Ahn HS. High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma. Bone marrow transplant 2015 Oct;50(10):1375-8. PMID:26098952

 

102. Kang HM, Lee HJ, Cho EY, Yu KS, Lee H, Lee JW, Kang HJ, Park KD, Shin HY, Choi EH. The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections. Pediatr Hematol Oncol. 2015 Nov;32(8):557-67. PMID: 26558811

 

103. Lee HJ, Lee B, Park JD, Jeong HJ, Choi YH, Ju HY, Hong CR, Lee JW, Kim H, Suh DI, Park KD, Kang HJ, Shin HY, Ahn HS. Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease. Drug Des Devel Ther. 2015 Dec 17;9:6489-95. PMID: 26719674

 

104. Lee S, Moon JS, Lee CR, Kim HE, Baek SM, Hwang S, Kang GH, Seo JK, Shin CH, Kang HJ, Ko JS, Park SG, Choi M. Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4. J Allergy Clin Immunol. 2016 Jan;137(1):327-30. PMID: 26478010

 

105. Piao Z, Kim HJ, Choi JY, Hong CR, Lee JW, Kang HJ, Park KD, Shin HY. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients. Int Immunopharmacol. 2016 Feb;31:132-139. PMID: 26735609

 

106. Seo JY, Lee KO, Yoo KH, Sung KW, Koo HH, Kim SH, Kang HJ, Park KD, Shin HY, Baek HJ, Kook H, Lyu CJ, Song JS, Lee MJ, Kim JY, Lim YT, Koh KN, Im HJ, Seo JJ, Kim HJ. Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2. Clin Genet. 2016 Feb;89(2):222-7. PMID: 26451869

 

107. Kook H, Chung NG, Kang HJ, Im HJ. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology. Int J Hematol. 2016 Apr;103(4):380-6. PMID: 26894608

 

108. Han MS, Lee HJ, Lee H, Choe YJ, Lee JW, Kang HJ, Park KD, Shin HY, Jung HJ, Choi EH. Risk Factors and Clinical Features of Cytomegalovirus Disease in Children Receiving Anticancer Chemotherapy. J Pediatr Hematol Oncol. 2016 Apr;38(3):e113-9. PMID:26523383

 

109. Ju HY, Kang HJ, Hong CR, Lee JW, Kim H, Park KD, Shin HY, Park JD, Choi EH, Lee HJ, Ahn HS. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2016 Jun;18(3):396-404. PMID: 27041364

 

110. Kang HJ, Hong KT, Lee JW, Kim H, Park KD, Shin HY, Lee SH, Yoo KH, Sung KW, Koo HH, Lee JW, Chung NG, Cho B, Kim HK, Koh KN, Im HJ, Seo JJ, Jung HJ, Park JE, Lee YH, Lim YT, Lim YJ, Kim SY, Yoo ES, Ryu KH, Lee JH, Park JA, Park SK, Ahn HS; Korean Society of Pediatric Hematology-Oncology. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Thymoglobulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies. Biol Blood Marrow Transplant. 2016 Aug;22(8):1455-9. PMID: 27090956

 

111. Lee JA, Jeon DG, Cho WH, Song WS, Yoon HS, Park HJ, Park BK, Choi HS, Ahn HS, Lee JW, Yoo KH, Sung KW, Koo HH, Kang HJ, Park KD, Shin HY, Koh KN, Im HJ, Seo JJ, Lim YJ, Baek HJ, Kook H. Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy. Pediatr Blood Cancer. 2016 Sep;63(9):1552-6. PMID: 27197055

 

112. Kim SY, Choi SA, Lee S, Lee JS, Hong CR, Lim BC, Kang HJ, Kim KJ, Park SH, Choi M, Chae JH. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations. Am J Med Genet A. 2016 Nov;170(11):3023-3027. PMID: 27411168

 

113. Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma. 2017 Jan;58(1):53-63. PMID: 27157296

 

114. Yun SO, Shin HY, Kang CY, Kang HJ. Generation of antigen-specific cytotoxic T lymphocytes with activated B cells. Cytotherapy. 2017 Jan;19(1):119-127. PMID: 27864016

 

115. Wun CM, Piao Z, Hong KT, Choi JY, Hong CR, Park JD, Park KD, Shin HY, Kang HJ. Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant. Int Immunopharmacol. 2017 Feb;43:62-69. PMID: 27960128

 

116. Koh KN, Im HJ, Kim H, Kang HJ, Park KD, Shin HY, Ahn HS, Lee JW, Yoo KH, Sung KW, Koo HH, Lim YT, Park JE, Park BK, Park HJ, Seo JJ. Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study. J Korean Med Sci. 2017 Apr;32(4):642-649. PMID: 28244291

 

117. Kim B, Lee JW, Hong KT, Yu KS, Jang IJ, Park KD, Shin HY, Ahn HS, Cho JY, Kang HJ. Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients. Sci Rep. 2017 May 10;7(1):1711. PMID: 28490733

 

118. Chung H, Yu KS, Hong KT, Choi JY, Hong CR, Kang HJ, Park KD, Shin HY, Lee S. A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring. Ther Drug Monit. 2017 Jun;39(3):208-210. PMID: 28328762

 

119. Rhee SJ, Lee JW, Yu KS, Hong KT, Choi JY, Ry Hong C, Park KD, Shin HY, Song SH, Kang HJ, Lee H. Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram. Am J Hematol. 2017 Jul;92(7):607-613. PMID: 28370238

 

120. Kim KH, Choi TH, Choi Y, Park YW, Hong KY, Kim DY, Choe YS, Lee H, Cheon JE, Park JB, Park KD, Kang HJ, Shin HY, Jeong JH. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial. JAMA Dermatol. 2017 Jun 1;153(6):529-536. PMID: 28423174

 

121. Yoon JH, Park KD, Kang HJ, Kim H, Lee JW, Kim SK, Wang KC, Park SH, Kim IH, Shin HY. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea. World J Pediatr. 2017 Aug;13(4):367-373. PMID: 28550392

 

122. Shin DW, Park SN, Kim SM, Im K, Kim JA, Hong KT, Choi JY, Hong CR, Park KD, Shin HY, Kang HJ, Kim HK, Lee DS. WHIM Syndrome With a Novel CXCR4 Variant in a Korean Child. Ann Lab Med. 2017 Sep;37(5):446-449. PMID: 28643496

 

123. Oh D, Yi NJ, Song S, Kim OK, Hong SK, Yoon KC, Ahn SW, Kim HS, Kim H, Kim HY, Kang HJ, Lee M, Lee KB, Lee KW, Suh KS. Split liver transplantation for retroperitoneal immature teratoma masquerading as hepatoblastoma. Pediatr Transplant. 2017 Nov;21(7):e13025. PMID: 28714114

 

124. An HY, Hong KT, Kang HJ, Choi JY, Hong C, Kim HY, Choi TH, Kang CH, Kim HS, Cheon JE, Park SH, Park JD, Park KD, Shin HY. Malignant peripheral nerve sheath tumor in children: A single-institute retrospective analysis. Pediatr Hematol Oncol. 2017 Nov;34(8):468-477. PMID: 29286874

 

125. Kim SI, Lee Y, Kim SK, Kang HJ, Park SH. Aggressive Supratentorial Ependymoma, RELA Fusion-Positive with Extracranial Metastasis: A Case Report. J Pathol Transl Med. 2017 Nov;51(6):588-593. PMID: 29161788

 

126. Choi YH, Jeong HJ, An HY, Kim YS, Lee EJ, Lee B, Kang HJ, Shin HY, Park JD. Early predictors of mortality in children with pulmonary complications after haematopoietic stem cell transplantation. Pediatr Transplant.  2017 Dec;21(8):e13062  PMID: 29027353

 

127. Hong KT, Choi JY, Hong CR, Kang HJ, Park KD, Shin HY. Therapy-related Acute Myeloid Leukemia After the Treatment of Primary Solid Cancer in Children: A Single-center Experience. J Pediatr Hematol Oncol. 2018 Jan;40(1):e23-e28. PMID: 29200163

 

128. Hong CR, Kang HJ, Park KD, Shin HY, Ahn HS. High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia. Int J Hematol.  2018 Mar;107(3):355-362. PMID: 29052026

 

129. Ji S, Lee JY, Schror J, Mazumder A, Jang DM, Chateauvieux S, Schnekenburger M, Hong CR, Christov C, Kang HJ, Lee Y, Han BW, Kim KW, Shin HY, Dicato M, Cerella C, Konig GM, Orlikova B, Diederich M. The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer. Cancer Lett. 2018 Mar 1;416:109-123. PMID: 29246646

 

130. Lee JW, Park SH, Kang HJ, Park KD, Shin HY, Ahn HS. ALK Protein Expression is Related to Neuroblastoma Aggressiveness, But is Not Independent Prognostic Factor. Cancer Res Treat. 2018 Apr;50(2):495-505. PMID: 28546523

 

131. Dho YS, Kim H, Wang KC, Kim SK, Lee JY, Shin HY, Park KD, Kang HJ, Kim IH, Park SH, Phi JH. Pediatric Spinal Epidural Lymphoma Presenting with Compressive Myelopathy: A Distinct Pattern of Disease Presentation. World Neurosurg. 2018 Jun;114:e689-e697.  PMID: 29550599

 

132. Park JE, Choi YH, Cheon JE, Kim WS, Kim IO, Ryu YJ, Kim YJ, Hong CR, Kang HJ. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation. Eur Radiol.  2018 Jun;28(6):2291-2298. PMID: 29294155

 

133. Kim H, Seo H, Park Y, Min BJ, Seo ME, Park KD, Shin HY, Kim JH, Kang HJ. APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia. Cancer Res Treat. 2018 Jul;50(3):823-834. PMID: 28882023

 

134. Park M, Park HJ, Lee JM, Ju HY, Park BK, Yu ES, Yang HK, Kim JY, Park SK, Lee YH, Shim YJ, Kim HS, Lee JA, Lim YJ, Cheuh HW, Park JK, Lee MJ, Kim SK, Choi HS, Hah JO, Park KD, Kang HJ, Shin HY. School performance of childhood cancer survivors in Korea: A multi-institutional study on behalf of the Korean Society of Pediatric Hematology and Oncology. Psychooncology. 2018 Sep;27(9):2257-2264. PMID: 29927510

 

135. Mazumder A, Lee JY, Talhi O, Cerella C, Chateauvieux S, Gaigneaux A, Hong CR, Kang HJ, Lee Y, Kim KW, Kim DW, Shin HY, Dicato M, Bachari K, Silva AMS, Orlikova-Boyer B, Diederich M. Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release. Cancer Lett. 2018 Sep 8;438:197-218. PMID: 30205168

 

136. Kim DY, Kim IH, Yoon SS, Kang HJ, Shin HY, Kang HC. Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation. Radiat Oncol. 2018 Sep 18;13(1):180. PMID: 30227866

 

137. Kang HJ, Loftus S, DiCristina C, Gree

参会记录:1

讲座视频:0

论文摘要:0

362

0

0

学术任务如下
日期 时间 会场 Session 角色 讲题
2021-12-11 10:35-11:55 血液与肿瘤专场 Hematology & Oncology

血液与肿瘤专场-上午 Hematology & Oncology (a.m)

主持 Moderator
2021-12-11 11:40-11:55 血液与肿瘤专场 Hematology & Oncology

血液与肿瘤专场-上午 Hematology & Oncology (a.m)

讨论 Discussant 讨论Discussion